Subjects: DOENÇAS REUMÁTICAS (PARASITOLOGIA;CLASSIFICAÇÃO), MICROSPORIDIA, INTESTINOS (MICROBIOLOGIA), ESPONDELITE ANQUILOSANTE(TERAPIA;DIANÓSTICO), ARTRITE REUMATOIDE (TERAPIA), TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?. Clinics, v. 66, n. 7, p. 1171-1175, 2011Tradução . . Disponível em: https://doi.org/10.1590/S1807-59322011000700008. Acesso em: 12 maio 2024.APA
Aikawa, N. E., Twardowsky, A. de O., Bonfá, E., Carvalho, J. F. de, Silva, C. A., Silva, I. L. A. F. e, et al. (2011). Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? Clinics, 66( 7), 1171-1175. doi:10.1590/S1807-59322011000700008NLM
Aikawa NE, Twardowsky A de O, Bonfá E, Carvalho JF de, Silva CA, Silva ILAF e, Ribeiro AC de M, Saad CGS, Moraes JCB, Toledo RA de. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? [Internet]. Clinics. 2011 ; 66( 7): 1171-1175.[citado 2024 maio 12 ] Available from: https://doi.org/10.1590/S1807-59322011000700008Vancouver
Aikawa NE, Twardowsky A de O, Bonfá E, Carvalho JF de, Silva CA, Silva ILAF e, Ribeiro AC de M, Saad CGS, Moraes JCB, Toledo RA de. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? [Internet]. Clinics. 2011 ; 66( 7): 1171-1175.[citado 2024 maio 12 ] Available from: https://doi.org/10.1590/S1807-59322011000700008